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BACKGROUND: High blood pressure (BP) is a risk factor for 
cardiovascular morbidity and mortality. While BP is regulated by the 
function of kidney, vasculature, and sympathetic nervous system, 
recent experimental data suggest that immune cells may play a role in 
hypertension.
METHODS: We studied the relationship between major white blood 
cell types and blood pressure in the UK Biobank population and used 
Mendelian randomization (MR) analyses using the ≈750 000 UK-
Biobank/International Consortium of Blood Pressure-Genome-Wide 
Association Studies to examine which leukocyte populations may be 
causally linked to BP.
RESULTS: A positive association between quintiles of lymphocyte, 
monocyte, and neutrophil counts, and increased systolic BP, diastolic BP, 
and pulse pressure was observed (eg, adjusted systolic BP mean±SE for 1st 
versus 5th quintile respectively: 140.13±0.08 versus 141.62±0.07 mm Hg 
for lymphocyte, 139.51±0.08 versus 141.84±0.07 mm Hg for monocyte, 
and 137.96±0.08 versus 142.71±0.07 mm Hg for neutrophil counts; all 
P<10–50). Using 121 single nucleotide polymorphisms in MR, implemented 
through the inverse-variance weighted approach, we identified a potential 
causal relationship of lymphocyte count with systolic BP and diastolic 
BP (causal estimates: 0.69 [95% CI, 0.19–1.20] and 0.56 [95% CI, 
0.23–0.90] of mm Hg per 1 SD genetically elevated lymphocyte count, 
respectively), which was directionally concordant to the observational 
findings. These inverse-variance weighted estimates were consistent 
with other robust MR methods. The exclusion of rs3184504 SNP in the 
SH2B3 locus attenuated the magnitude of the signal in some of the MR 
analyses. MR in the reverse direction found evidence of positive effects of 
BP indices on counts of monocytes, neutrophils, and eosinophils but not 
lymphocytes or basophils. Subsequent MR testing of lymphocyte count 
in the context of genetic correlation with renal function or resting and 
postexercise heart rate demonstrated a positive association of lymphocyte 
count with urine albumin-to-creatinine ratio.
CONCLUSIONS: Observational and genetic analyses demonstrate a 
concordant, positive and potentially causal relationship of lymphocyte 
count with systolic BP and diastolic BP.
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High blood pressure (BP) causes cardiovascular dis-ease, including coronary heart disease (CHD) and stroke. While classical BP regulation is controlled 
by the function of kidney, vasculature and sympathet-
ic nervous system, recent experimental data suggest 
that immune cells may play an important role in the 
development of hypertension.1–5 For example, immune 
cells infiltrating heart,6 perivascular adipose tissue, or 
kidneys contribute to dysfunction of these organs and 
can mediate high BP.2 RAG1–/– mice7 or rats,8 lacking 
functional T and B lymphocytes, are protected from ex-
perimental hypertension, and transfer of T lymphocytes 
restores the hypertensive phenotype.7 Moreover, target-
ing B cells,9 monocytes, and neutrophils as well as tar-
geting inflammasome10–13 shows their contribution to 
vessel remodeling and hypertension. While most data 
originate from experimental models, the relationships 
between white blood cells and hypertension remains 
poorly defined in humans.
Well-powered, genome-wide association studies 
(GWAS) have identified hundreds of single nucleotide 
polymorphisms (SNPs) associated with BP-related traits 
or circulating blood cell indices.14,15 This creates an op-
portunity to test genetic, potentially causal relation-
ships between these and other, clinically relevant car-
diovascular traits using the Mendelian randomization 
(MR) approach. In brief, MR exploits characteristics of 
the human genome—principally its random allocation 
and nonmodifiable nature—to make potentially causal 
deductions on the relationship of an exposure on a trait 
or disease.16 Indeed, previous studies using such genet-
ic approaches identified evidence in support of a causal 
relationship between white blood cell parameters such 
as lymphocytes and risk of CHD, making the explora-
tion of the role of white blood cells in altering BP of 
particular interest.15
In the present study, we studied the relationship be-
tween major white blood cell types and BP in the UK 
Biobank (UKB) population and used MR analysis using 
data generated from large GWAS to examine whether 
leukocyte subpopulations may be causally linked to BP.
METHODS
UKB data are available on application for data access (http://
www.ukbiobank.ac.uk/). Data concerning SNPs used in MR 
analyses, linking white blood cell count and BP indices, are 
available in the Excel file in the Data Supplement. GWAS 
summary statistics of the CKDGen (Chronic Kidney Disease 
Genetics) Consortium (http://ckdgen.imbi.uni-freiburg.
de/), white blood cell counts (http://www.bloodcellgenetics.
org/), heart rate (HR) phenotypes (https://www.cardiomics.
net/download-data, https://data.mendeley.com/datasets/
tg5tvgm436/1) and BP indices (UKB+ICBP [International 
Consortium for Blood Pressure]; https://www.ebi.ac.uk/gwas/
downloads/summary-statistics) are available online. The ICBP 
GWAS summary statistics can be assessed through the ICBP 
Consortium.
Testing the Observational Association 
Between Blood Cell Counts and BP 
Indices
UKB recruited 502 639 participants (37 to 73 years of age) 
from 22 assessment centers across the United Kingdom 
between 2007 and 2010. Baseline biological measurements 
were recorded, and touchscreen questionnaires were adminis-
tered, as described elsewhere.17 UKB received ethical approval 
from the North West Multi-Center Research Ethics Committee 
(11/NW/03820). All participants gave written informed con-
sent before enrollment in the study, which was conducted in 
accordance with the principles of the Declaration of Helsinki. 
Using self-reported, ethnic background information, we 
selected 442 604 white British participants of the UK Biobank 
study to assess the effect of quintiles of circulating monocyte, 
lymphocyte, eosinophil, neutrophil, and basophil counts on 
systolic BP (SBP), diastolic BP (DBP), and pulse pressure (PP).17 
Whereas blood cell indices often correlate with each other 
(Table I in the Data Supplement), these 5 subpopulations were 
among 13, out of 36, blood cell indices selected by Astle et 
al as relatively independent and approximated all other white 
blood cell indices including absolute and percentage counts 
(eg, blood neutrophil count strongly correlated with total 
white blood cell count and percentage of lymphocytes).15,18
The average of 2 automated, sitting BP readings (see 
Data Supplement for details regarding BP measurement 
procedure) was calculated and used in final analyses, and 
individuals with only 1 reading available (9.2% for SBP or 
DBP) were excluded from further analyses, leaving 384 721 
individuals with available white blood cell counts for final 
analysis (Table). Repeated blood pressure measurements 
were highly correlated.19
BP values from individuals on BP-lowering medications 
were adjusted in the same way as compared with GWAS 
on BP indices in the UKB and ICBP14,20 (ie, by adding 15 
and 10 mm Hg to SBP and DBP, respectively;21 see Figure I 
in the Data Supplement for distribution of BP indices). We 
Clinical Perspective
What Is New?
• This cross-sectional and genetic study found poten-
tially causal, positive effects of total blood lympho-
cyte count with regards to blood pressure.
• Among mechanisms that might mediate this rela-
tionship, we found evidence that blood lympho-
cyte count might influence albuminuria.
• This study may also support a reverse, potentially 
causal positive effect of blood pressure indices 
on blood neutrophil, monocyte, and eosinophil 
counts.
What Are the Clinical Implications?
• High blood lymphocyte count may play a causal 
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also performed separate sensitivity analyses after exclusion 
of individuals reporting BP-lowering medication use, using 
the same quintile boundaries as compared with the whole 
cohort. White blood cells were measured on fresh samples as 
an absolute number per unit volume, and their component 
leukocytes (lymphocytes, monocytes, neutrophils, eosino-
phils, and basophils) as absolute measures and proportions 
of the overall white blood cells; all using an automated, 
clinically validated, Coulter LH 750. Calibration and quality 
control were performed in line with the manufacturer’s rec-
ommendations.18 Further details of these measurements can 
be found in the UK Biobank online showcase and protocol 
(http://www.ukbiobank.ac.uk). While quintiles of monocyte, 
lymphocyte, eosinophil, and neutrophil counts contained, on 
average, 76 944±4588 subjects, quintiles of basophil count 
were less balanced, with  96 897 subjects (all subjects with 
no basophils detected), 31 792, 128 937, 55 910, and 77 185 
individuals in the 1st, 2nd, 3rd, 4th, and 5th quintiles, respec-
tively (see Figure II in the Data Supplement for distributions of 
white blood cell counts).
MR Analyses Testing Causal Effect of 
Blood Cell Count on BP Indices
Instrumental Variables
We selected SNPs that associated with the level of circulat-
ing monocyte, lymphocyte, eosinophil, basophil, or neutrophil 
counts at genome-wide significance (P<8.31×10–9) in analysis 
of UKB and INTERVAL studies comprising 173 480 individuals.15 
Final analyses included common (minor allele frequency>5%) 
and uncorrelated (r2<0.2; validated in European British panel 
using LDlink)22 SNPs available in GWAS on outcome variables. 
Palindromic SNPs with a minor allele frequency>40% in the 
exposure GWAS, as well as SNPs from the major histocompati-
bility complex region (chr6:20 000 000–40 000 000, GRCh37), 
which likely possess pleiotropic effects, were excluded from 
analyses.
Outcome Variables
Our primary analysis examined whether there exists a rela-
tion between 5 selected blood cell indices and SBP, DBP, 
or PP on the basis of genetic effect estimates published by 
Evangelou et al in meta-analysis of 2 independent GWAS, 
the UKB and ICBP, comprising 757 601 individuals.14 We 
estimated that approximately 17.6% of individuals from 
the UKB+ICBP GWAS14 were also included in the GWAS 
on blood cell counts.15 Thus, to ensure that this over-
lap did not overly influence our results (eg, because of 
overfitting or winner’s curse),16 a sensitivity analysis was 
performed using GWAS estimates derived solely from the 
ICBP consortium comprising 299 024 individuals.14 Of 
note, GWAS analysis on BP indices was adjusted for body 
mass index,14 while GWAS analysis on blood cell counts 
was adjusted for log-height and log-weight, which 
implicitly adjusted for body mass index.15 Therefore both 
GWAS of exposures and outcomes adjusted for adipos-
ity-related traits, potentially limiting confounding caused 
by collider bias.23
A secondary analysis aimed to identify an intermediate 
phenotype, which may mediate the causal effects, if pres-
ent, of lymphocyte count on BP. Therefore, using published 
GWAS summary data, we selected traits related to kidney 
and heart function that have previously demonstrated a 
causal link to BP or hypertension through genetic analy-
ses. This included resting HR,24 increase in HR from resting 
level to peak exercise level,25 estimated glomerular filtra-
tion rate assessed in individuals of European ancestry,26 
and urine albumin-to-creatinine ratio (UACR) derived from 
2 different studies, that is, the CKDGen Consortium, and 
meta-analysis of the UK Biobank and CKDGen consor-
tium.27,28 All participants, included in the individual studies 
within the CKDGen and ICBP consortia, provided written 
informed consent and studies were approved by their local 
research ethics committees and institutional review boards 
as applicable.20,26–28
Reverse MR Analyses
We considered 885 SNPs replicated in 1- or 2-stage analyses 
in a GWAS on BP indices by Evangelou et al.14 Among these, 
we selected 883 independent SNPs (r2<0.2 validated in the 
European British panel using LDlink),22 and associated with 
Table. Characteristics of 384 721 White, British Participants From the 
UK Biobank Study Who Were Included in the Analysis
Characteristic Value
Men, n (%) 177 322 (46.1)
Age, y, mean (SD) 56.88 (7.99)
Body mass index, kg/m2, mean (SD) 27.37 (4.72)
Systolic blood pressure, mm Hg, mean (SD) 138.12 (18.58)
Diastolic blood pressure, mm Hg, mean (SD) 82.21 (10.08)
Pulse pressure, mm Hg, mean (SD) 55.91 (13.62)
Blood cell count, 106 cells/mL, median (interquartile range)
  Lymphocytes 1.86 (1.50–2.28)
  Neutrophils 4.05 (3.30–4.99)
  Monocytes 0.45 (0.37–0.57)
  Eosinophils 0.14 (0.10–0.21)
  Basophils 0.02 (0.00–0.04)
Smoking status, n (%)
  Never smoker 208 606 (54.4)
  Previous smoker 135 988 (35.5)
  Current smoker 38 782 (10.1)
Alcohol intake frequency, n (%)
  Daily or almost daily 81 946 (21.3)
  3 or 4 times per week 92 342 (24.0)
  1 or 2 times per week 101 370 (26.4)
  1 to 3 times per month 42 678 (11.1)
  Special occasions only 40 900 (10.6)
  Never 25 222 (6.6)
Salt intake (salt added to food), n (%)
  Never or rarely 218 726 (56.9)
  Sometimes 106 037 (27.6)
  Usually 43 212 (11.2)
  Always 16 707 (4.3)
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SBP, DBP, or PP at P<5×10–8 in the meta-analysis of the UKB 
and ICBP consortia,14 and used these as instrumental vari-
ables (IVs) in an MR analysis on 5 selected blood cell indices.15 
Palindromic SNPs with a minor allele frequency >40% in the 
exposure GWAS, as well as SNPs from the major histocom-
patibility complex region, were excluded from these analyses.
Statistical Analysis
General linear model in SPSS (version 25.0) was used to test 
the association of quintiles of cell counts on SBP, DBP, and PP 
level while adjusting for sex, age, age squared, body mass 
index, smoking status (3 categories: never, former, and cur-
rent), and alcohol intake frequency (6 categories: never, spe-
cial occasions only, 1 to 3 times a month, 1 or 2 times a week, 
3 or 4 times a week, and daily or almost daily). Quintile-specific 
estimated marginal means were reported and compared 
using analysis of variance. To verify the observed associations, 
we performed similar analyses with additional adjustment 
for salt intake (Table 1)1,29 or using quantile regression using 
quantreg package in R (version 3.6.2) with the 3rd quintile set 
as a reference. To model the continuous relationship between 
blood cell counts and medication-adjusted BP indices quantile 
regression, the generalized additive model using mgcv pack-
age (version 1.8–31),30 and general linear model analyses in 
R were used. Cubic regression spline smooth was applied to 
cell count parameters and generalized additive model analy-
ses were also adjusted for body mass index, age, age squared, 
sex, smoking status, and alcohol intake frequency.
Inverse-variance weighted (IVW) analyses were performed 
using MendelianRandomization package in R.31 Additional sen-
sitivity analyses were performed using methods that are more 
robust to violations of MR assumptions, that is, weighted median 
approach, allowing up to 50% of the weights to be invalid IVs,31 
MR-Egger method, which can include SNPs with pleiotropic 
effects that are not proportional to the effects of these SNPs on 
exposure,16,31 as well as MR-PRESSO (Mendelian Randomization 
Pleiotropy Residual Sum and Outlier) method, which identifies 
and excludes SNPs that most likely display pleiotropic effects.32 
Leave-one-out sensitivity analyses were performed using 
TwoSampleMR package in R.33 False discovery rate–based cor-
rection was applied to P values derived from MR analyses.
RESULTS
Levels of White Blood Cell 
Subpopulations Associate With BP in the 
UKB
An association between quintiles of all cell types and SBP, 
DBP, and PP was observed (Figure 1). While the differenc-
es between quintiles showed strong evidence of associa-
tions, even after Bonferroni correction for multiple test-
ing, the association of blood neutrophil count with all 3 
BP indices was the strongest, relatively, as compared with 
the other white blood cells analyzed (eg, difference in ad-
justed SBP between the 5th and 1st quintile in mm Hg 
[95% CI]: 4.74 for neutrophil [4.47–5.01], 2.33 for 
monocyte, [2.06–2.60], 1.49 for lymphocyte [1.22–1.76], 
0.63 for basophil [0.37–0.88], and −0.95 for eosinophil 
counts [−1.21 to −0.69]; Figure 1). This was further sup-
ported by analysis of continuously defined white blood 
cell counts (Table II in the Data Supplement).
Of note, the 1st quintile of eosinophil count was as-
sociated with higher SBP and PP compared with any 
other quintile (Figure 1). Associations identified in the 
aforementioned observational analyses using general 
linear model were confirmed using quantile regression 
analysis (Table III in the Data Supplement), after exclu-
sion of individuals on BP-lowering medication (Figure 
III in the Data Supplement), or after additional adjust-
ment for salt intake (Figure IV in the Data Supplement). 
Generalized additive model analyses identified evidence 
(P<5×10–4) of smooth terms of all analyzed blood cell 
counts on SBP, DBP, and PP. In particular, count of 
monocytes and neutrophils was associated with SBP in 
a dose-dependent manner (Figure V in the Data Sup-
plement), while positive effects of lymphocytes on SBP 
could be observed above the 2nd quintile of lympho-
cyte count (Figure V in the Data Supplement). In ad-
dition, generalized additive model analyses confirmed 
protective effect of higher eosinophil count on all BP 
indices (Figure V in the Data Supplement).
MR Analysis of White Blood Cell Counts 
and Blood Pressure Indices
We next aimed to investigate causal relationships be-
tween major white blood cell counts and BP indices us-
ing 121, 87, 146 (147 for DBP analysis), 126 (127 for 
DBP analysis), and 50 uncorrelated SNPs used as IVs for 
analysis of total lymphocyte, neutrophil, monocyte, eo-
sinophil, and basophil counts, respectively (see Excel file 
in the Data Supplement for a list of all SNPs used as IVs).
We identified positive, potential causal relationships 
between lymphocyte count with SBP and DBP, concor-
dant in all analytic approaches (Figure 2 and Table IV 
in the Data Supplement). In particular, after false dis-
covery rate correction for multiple testing, IVW and 
MR-PRESSO methods demonstrated a potential causal 
relationship between lymphocyte count and both BP in-
dices (with a 1 SD genetically instrumented higher lym-
phocyte count leading to a 0.69 mm Hg [95% CI, 0.19–
1.20] higher SBP; P=0.007 and 0.56 mm Hg [95% CI, 
0.23–0.90] higher DBP; P=0.001), with similar findings 
when using robust MR approaches, including MR-Egg-
er and weighted median methods (Figure 2 and Table IV 
in the Data Supplement). Of note, using ICBP-only data 
(with no participant overlap), we demonstrated consis-
tent, positive effects between total lymphocyte count 
and both SBP and DBP using all 4 analytical methods 
(Table V in the Data Supplement).
All MR analytic approaches demonstrated a relation-
ship between total eosinophil count and higher DBP level 
(Figure 2 and Table IV in the Data Supplement), and this 
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the ICBP consortium (Table V in the Data Supplement). 
Of note, MR-Egger found relatively strong evidence for 
pleiotropy (Tables IV and V in the Data Supplement), 
and causal effects were in the opposite direction when 
compared with the observational findings (Figure 1). No 
association concerning total neutrophil, monocyte, or 
basophil counts, observed in the primary analysis using 
UKB+ICBP BP estimates (Figure  2 and Table IV in the 
Figure 1. Levels of 5 white blood cell types are associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP) 
in the UK Biobank.
Estimated marginal means of blood pressure indices, from general linear model analysis adjusted for sex, age, age squared, body mass index, smoking status, and 
alcohol intake frequency, are presented according to quintiles of counts of white blood cell subpopulations. All ANOVA tests, assessing global between-quintile 
differences in blood pressure indices were significant at P<10–11. Post hoc tests revealed that all comparisons between the 1st and the 5th quintile of any cell type 
count with respect to any blood pressure index were significant at Bonferroni-corrected P<0.05, given 150 tests (5 types of blood cell counts×3 blood pressure 
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Data Supplement), could be replicated using ICBP-only 
data at a nominal threshold for significance (Table V in 
the Data Supplement).
Inspection of scatter plots, visualizing the associa-
tions of individual SNPs (used as IVs) with BP indices and 
lymphocyte or eosinophil counts, as well as leave-one-
out sensitivity analyses, identified a single variant in the 
ATXN2/SH2B3 locus that influenced the IVW associa-
tion (Figures VI and VII in the Data Supplement). Exclu-
sion of these variants from MR analyses on lymphocyte 
count (rs3184504) or eosinophil count (rs653178) at-
tenuated the causal estimates (Figure 3). In this scenario 
(ie, on excluding rs653178), the relationship of eosino-
phil count with SBP attenuated, while the magnitude of 
the positive association of lymphocyte count with SBP 
(weighted median and MR-PRESSO methods) or DBP 
(IVW and MR-PRESSO methods; Figure 3) was reduced.
Reverse MR Analysis Assessing the Effect 
of BP on Blood Cell Counts
To further understand a source of observational asso-
ciations between BP and blood cell counts, we used BP-
associated variants as IVs to explore the relationship of 
Figure 2. Mendelian randomization (MR) analyses testing the effects of 5 white blood cell subpopulation counts on systolic blood pressure (SBP), 
diastolic blood pressure (DBP), and pulse pressure (PP).
Results obtained using 4 MR methods (inverse-variance weighted [IVW], Mendelian randomization-Egger [MR-Egger], weighted median, and MR-PRESSO [Mende-
lian Randomization Pleiotropy Residual Sum and Outlier]) are presented as a heat map representing causal estimates (1 SD of BP index per 1 SD of cell count). BP 
indicates blood pressure. *False discovery rate P<0.05 for a particular MR approach. 
Figure 3. Mendelian randomization (MR) analyses testing effect of lymphocyte or eosinophil counts on systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) levels, before and after exclusion of a single variant from the SH2B3/ATXN2 (SH2B adaptor protein 3/ataxin 2) locus.
Results of 4 MR methods (inverse-variance weighted [IVW], MR-Egger, weighted median, and MR-PRESSO [Mendelian Randomization Pleiotropy Residual Sum and 
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BP traits with blood cell traits in the reverse direction. 
We found no evidence of association between any of 
the BP index and lymphocyte or basophil count (Fig-
ure 4 and Table VI in the Data Supplement; see Excel 
file in the Data Supplement for a list of all SNPs used as 
IVs). Of interest, MR analyses supported the existence 
of positive effects of SBP and DBP on monocyte and 
eosinophil count, while positive effects of SBP and PP 
were identified for neutrophil count (Figure 4 and Table 
VI in the Data Supplement). Inspection of scatter plots, 
visualizing the effects of all individual IVs on cell counts 
and BP indices, as well as leave-one-out sensitivity anal-
yses, found that while rs3184504 SNP in SH2B3 inflat-
ed the IVW causal estimates for neutrophil, monocyte, 
and eosinophil counts, the estimates remained robust 
to exclusion of this particular SNP (Figures VIII and IX in 
the Data Supplement).
Renal Function and Heart Rate in the 
Context of the Circulating Lymphocyte 
Counts
Primary observational association and genetic analyses 
demonstrated concordant effect directions of lympho-
cyte count on SBP and DBP. Thus, we tested lymphocyte 
counts in the context of genetic correlation with kid-
ney function and heart rate parameters. An evidence 
of positive association was found between the level of 
circulating lymphocytes and UACR using MR-PRESSO 
and IVW, but not other methods (Table VII in the Data 
Supplement). No association between the level of cir-
culating lymphocytes and resting HR, increase in HR 
from resting level to peak exercise level, or estimated 
glomerular filtration rate was identified (Table VII in the 
Data Supplement). Inspection of scatter plots, visualiz-
ing effects of all IVs on lymphocyte count and UACR, 
as well as leave-one-out sensitivity analyses, found that 
IVW causal estimates remained robust to exclusion of 
any single SNP from MR analysis (Figures X and XI in the 
Data Supplement).
DISCUSSION
Using an MR approach, the present study identified 
a positive, potentially causal relationship between 
circulating blood lymphocyte counts and BP levels. 
This is of importance given the findings reported in 
a recent study that identified evidence in support of 
a causal relationship between circulating lymphocytes 
and risk of CHD.15 Although the genetic effect of lym-
phocyte count on CHD reported in previous studies 
was, at least partially, driven by variants in the major 
histocompatibility complex locus,15 our study provides 
a plausible mechanism by which lymphocytes might 
cause CHD, through increases in BP parameters. Of 
note, our MR analysis identified a potential causal re-
lationship between total lymphocyte count and both 
SBP and DBP that was independent of the major his-
tocompatibility complex region. This is of importance 
because SBP and DBP are recognized causal risk fac-
tors for cardiovascular disease.34
The MR concept has been widely used to elucidate 
potential causal relationships between various risk 
factors and disease outcomes. Using this approach, 
it has been shown that myeloid and lymphoid blood 
cell counts are causally related to several autoimmune 
diseases, yet not to chronic kidney disease or type 2 
diabetes mellitus.15 MR analysis has been also used to 
make causal inference in the pathogenesis of hyperten-
sion. For example, lower estimated glomerular filtration 
rate causally influences DBP and hypertension.35 A re-
cent study on urinary biomarkers in the UKB identified 
Figure 4. Reverse Mendelian randomization (MR) analyses testing the effects of systolic blood pressure (SBP), diastolic blood pressure (DBP), and 
pulse pressure (PP) on cell counts of white blood cell subpopulations.
Results obtained using 4 MR methods (inverse-variance weighted [IVW], MR-Egger, weighted median, and MR-PRESSO [Mendelian Randomization Pleiotropy 
Residual Sum and Outlier]) are presented as a heat map representing causal estimates (1 SD cell count per 1 SD blood pressure [BP] index).*False discovery rate 
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genetic correlation between SBP and 4 parameters re-
flecting renal function, including UACR.36 Moreover, 
genetic risk scores of resting HR or HR response to ex-
ercise are associated with BP,24,25 while genetic deter-
minants of brachial artery diameter,37 associate with BP 
as well.14 These results, derived from GWAS, support a 
key role of kidney in the regulation of BP and suggest a 
tight relation between BP and function of sympathetic 
nervous system, controlling HR, and vasculature.
Of note, even though neutrophil count appeared to 
be the strongest component of white blood cells as-
sociated with SBP and DBP in an observational analysis 
in the UKB, we did not identify evidence of a causal 
effect on these BP indices in MR analysis. This may indi-
cate confounding of the observational analysis, reverse 
causation, which was, at least partially, identified in the 
present study, or more acute effects of neutrophil count 
on BP that might not be captured by MR analysis. In-
deed, data from the CANTOS trial (Canakinumab Anti-
Inflammatory Thrombosis Outcomes Study), which in-
vestigated the use of canakinumab, an IL-1β blocker, in 
cardiovascular disease prevention, demonstrated that 
although the studied drug was profoundly neutrope-
nic,38,39 it had no effect on BP,40 yet it should be empha-
sized that this was not a specific, neutrophil-targeting 
intervention. Inflammation may cause cardiovascular 
disease through a myriad of pathways, and BP is only 
one potential component of this.
Our data are important as they provide mechanistic 
context to observational associations that earlier stud-
ies have reported, indicating a relationship between 
peripheral blood lymphocytes and hypertension. In our 
previous studies, we have identified that hypertensive 
patients are characterized by increased central mem-
ory, Th17 as well as IFN-γ producing immunosenes-
cent or effector CD8+ cells.41,42 Moreover, circulating 
lymphocytes have been associated with microvascular 
remodeling in hypertension.43 At the same time, we 
have recently observed relations between monocyte 
subpopulations and hypertension.44 Our present data, 
which include bidirectional assessment of genetic as-
sociation between BP and blood cell counts, help to in-
terpret these and may indicate that increases in mono-
cytes with increasing blood pressure, are, similarly to 
neutrophils, most likely a consequence rather than a 
cause of hypertension.
The mechanism by which white blood cells, and es-
pecially lymphocytes, may cause hypertension remains 
unclear. Experimental animal data suggest that the ef-
fects of lymphocytes might be mediated by modulating 
vascular function, sympathetic outflow, and hyperten-
sion as well as renal sodium reabsorption and salt han-
dling by antigen presenting cells.1–3,5,29 Using available, 
large-scale GWAS, we aimed to identify a target organ, 
whose function is causal to BP and might be affect-
ed by lymphocyte count. Our analysis of phenotypes 
related to kidney, and sympathetic nervous system 
function, demonstrated that genetically defined, higher 
total lymphocyte count related to a higher UACR us-
ing MR-PRESSO and IVW analyses, yet the associations 
were weaker using other analytic approaches. On the 
other hand, associations between lymphocyte count 
and UACR could be observed using UACR data de-
rived from 2 different studies,27,28 which may support 
a causal link between lymphocyte count and albumin-
uria. Furthermore, this may indicate that lymphocytes 
affect BP via UACR, though it might be as well that 
lymphocytes affect UACR through independent causal 
pathways that include BP. Of note, recent studies indi-
cate that a bidirectional association between albumin-
uria and BP exists.45 Moreover, whereas genetic liability 
to albuminuria associates with hypertension, stroke, 
and heart failure, it does not associate with chronic kid-
ney disease,45 which may explain the lack of a causal 
relationship between lymphocyte count and estimated 
glomerular filtration rate in the present study. As a con-
sequence, it has been proposed that albuminuria may 
have tubular origins, caused by sodium retention in the 
distal tubule.46
Other than the analyses of the genetic correlation 
between lymphocyte count and UACR, important bio-
logical information can be obtained while selecting 
genes in proximity to SNPs that associate with both 
lymphocyte count and BP indices in the concordant di-
rection (Table VIII in the Data Supplement). Many genes, 
whose function may be affected by selected SNPs, have 
been investigated in the context of BP regulation in 
vivo, and previous studies linking genetics of hyperten-
sion to lymphocyte biology focused on SH2B3 as key 
driver for hypertension (Table VIII in the Data Supple-
ment). For example, an in vivo study demonstrated ex-
acerbated hypertension, vascular dysfunction, and infil-
tration of IFNγ-producing CD8+ T cells in response to 
angiotensin II in Sh2b3 knockout animals as compared 
with wild type mice.47 SNP rs3184504 is a missense 
mutation within SH2B3 and leads to an R262W amino 
acid change in Lnk,48 which is a negative regulator of 
hematopoiesis and TNFα signaling in endothelial cells 
and may play a role in integrin signaling.49 Of interest, 
the SH2B3 locus has been associated with various car-
diovascular-related traits and diseases, including CHD,50 
and its effect on blood pressure may be at least partially 
mediated by influencing β-2-microglobulin levels in hu-
mans.51 This suggests a potentially pleiotropic effect of 
SH2B3 on BP level. Of importance, sensitivity analyses 
performed in the present study identified rs3184504 
SNP in SH2B3 as a potential pleiotropic outlier, and its 
exclusion led to attenuation of the MR relationships cal-
culated by all analytic approaches. However, after ex-
clusion of rs3184504 SNP, evidence of potential causal 
effect of lymphocyte count on BP was retained in IVW, 
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The interpretation of estimates derived from MR can 
be challenging.52 Nevertheless, MR relies on assump-
tions that may be untestable (eg, exclusion restriction, 
especially in the presence of unknown/unmeasured po-
tential confounding).53 For example, horizontal pleiot-
ropy, the phenomenon where genetic variants indepen-
dently associate with traits other than the ones under 
investigation, can lead to confounding of the MR esti-
mates. The susceptibility of the estimates derived from 
MR to such horizontal pleiotropy can be investigated 
through the application of sensitivity analyses that are 
more robust to such types of pleiotropy, as performed 
in the present study with MR-Egger and weighted me-
dian approaches.16 Although none of these methods, 
when used individually, entirely protects the findings 
from MR analyses from the influence of potential pleio-
tropic effects, a consistency of effect estimate derived 
across multiple sensitivity analyses adds confidence to 
the plausibility of the presence of a true underlying 
causal effect. Other forms of confounding in MR exist, 
such as population structure.53 In the present analysis, 
GWAS used in the identification of white blood cell 
counts and BP indices used methodology that take into 
account cryptic relatedness and population stratifica-
tion,14,15 which should minimize the potential for such 
sources of confounding. A further vulnerability is the 
potential for overfitting in the context of having used 
the same dataset for discovery (ie, GWAS) and MR.54 
Additionally, we used the ICBP GWAS on BP indices,14 
characterized by no individuals overlapping with the 
GWAS on white blood cell counts, to confirm the lack 
of overfitting of the effects of genetically defined blood 
lymphocyte count on SBP and DBP levels.
In contrast with MR analyses, our observational 
results are likely to be more susceptible to errors in-
duced by confounding or reverse causation phenom-
ena. While the associations of white blood cell counts 
with BP seem to be independent of commonly used 
potential confounders such as sex, age, body mass 
index, salt/alcohol intake, or smoking habits, we can-
not exclude the existence of residual confounding 
by variables influencing blood cell count and BP as-
sociation. The reverse-causation phenomenon is, by 
definition, not feasible to address in the context of 
cross-sectional data, thus motivating the need for ei-
ther prospective studies with comprehensive follow-
up or approaches were reverse causation cannot be a 
phenomenon, such as MR approaches or randomized 
controlled trials.
In summary, the present study identified evidence in 
support of a potential causal link between elevated lym-
phocyte count and higher BP. The molecular mechanism 
of this association is possibly independent of the clas-
sical regulatory mechanisms related to kidney function 
or heart rate but might involve pathways related to al-
buminuria. Furthermore, results of reverse MR analyses 
may support potential causal effects of increased BP on 
higher levels of blood neutrophil, monocyte, and eo-
sinophil but not lymphocyte or basophil counts.
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